GT199800136A - Formas de dosificacion farmaceuticas solidas. - Google Patents

Formas de dosificacion farmaceuticas solidas.

Info

Publication number
GT199800136A
GT199800136A GT199800136A GT199800136A GT199800136A GT 199800136 A GT199800136 A GT 199800136A GT 199800136 A GT199800136 A GT 199800136A GT 199800136 A GT199800136 A GT 199800136A GT 199800136 A GT199800136 A GT 199800136A
Authority
GT
Guatemala
Prior art keywords
dosage forms
pharmaceutical dosage
solid pharmaceutical
water
pharmaceutical
Prior art date
Application number
GT199800136A
Other languages
English (en)
Inventor
Ghebre-Sellassie Isaac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199800136A publication Critical patent/GT199800136A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

ESTA INVENCION PROPORCIONA FORMAS DE DOSIFICACION SOLIDAS DE AGENTES FARMACEUTICOS ESCASAMENTE SOLUBLES EN AGUA. MAS PARTICULARMENTE, LA INVENCION ES UNA COMPOSICION FARMACEUTICA EN FORMA DE UNA DISPERSION DE PARTICULAS SOLIDAS DE UN INGREDIENTE FARMACEUTICO EN PARTICULAS DISPERSADO EN UNA MATRIZ DE UN POLIMERO SOLUBLE EN AGUA COMO POLIVINILPIRROLIDONA, HIDROXIPROPIL CELULOSA, O HIDROXIPROPIL METILCELULOSA.
GT199800136A 1997-08-21 1998-08-20 Formas de dosificacion farmaceuticas solidas. GT199800136A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5619597P 1997-08-21 1997-08-21

Publications (1)

Publication Number Publication Date
GT199800136A true GT199800136A (es) 2000-02-11

Family

ID=22002810

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800136A GT199800136A (es) 1997-08-21 1998-08-20 Formas de dosificacion farmaceuticas solidas.

Country Status (17)

Country Link
US (1) US20010048946A1 (es)
EP (1) EP1011640A1 (es)
JP (1) JP2001515029A (es)
KR (1) KR20010023085A (es)
AR (1) AR018252A1 (es)
AU (1) AU8600098A (es)
BR (1) BR9811972A (es)
CA (1) CA2292586C (es)
CO (1) CO4960652A1 (es)
GT (1) GT199800136A (es)
HN (1) HN1998000115A (es)
NZ (1) NZ502869A (es)
PA (1) PA8458101A1 (es)
PE (1) PE109599A1 (es)
SV (1) SV1998000104A (es)
WO (1) WO1999008660A1 (es)
ZA (1) ZA987551B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0182801B1 (ko) * 1991-04-16 1999-05-01 아만 히데아키 고체 분산체의 제조방법
US5503092A (en) * 1991-08-02 1996-04-02 Wilcom Tufting Pty. Ltd. Method and system of tufting
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
SK8562002A3 (en) 1999-12-23 2003-10-07 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE60143704D1 (de) * 2000-09-25 2011-02-03 Nippon Shinyaku Co Ltd Verfahren zur herstellung einer medizinischen festen dispersion
ATE293439T1 (de) * 2000-12-07 2005-05-15 Warner Lambert Co Verfahren und system zur gleichmä igen arzneistoffabgabe
ES2333645T3 (es) 2001-06-22 2010-02-25 Bend Research, Inc. Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros.
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
EP1469832B2 (en) 2002-02-01 2016-10-26 Bend Research, Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
MXPA05000977A (es) * 2002-08-12 2005-05-16 Pfizer Prod Inc Composiciones farmaceuticas de farmacos semiordenados y polimeros.
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
GB0315012D0 (en) * 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
US8273371B2 (en) * 2003-06-27 2012-09-25 Johan Adriaan Martens Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045062A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
CA2532931A1 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
JP2007513145A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2598204C (en) 2004-11-09 2015-01-13 Board Of Regents, The University Of Texas System Stabilized hme composition with small drug particles
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
JP5256739B2 (ja) * 2004-12-30 2013-08-07 ピエール・ファーブル・メディカマン ビンカアルカロイド誘導体の安定固体分散体とその製造方法
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
FR2880274B1 (fr) * 2004-12-30 2007-04-13 Pierre Fabre Medicament Sa Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication
RU2405539C2 (ru) * 2005-05-10 2010-12-10 Новартис Аг Экструзионный способ приготовления композиций, содержащих плохо прессующиеся лекарственные соединения
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
WO2008074097A1 (en) * 2006-12-21 2008-06-26 Alphapharm Pty Ltd Pharmaceutical compound and composition
US20110092515A1 (en) * 2008-07-03 2011-04-21 Zhihui Qiu Melt granulation process
WO2010136604A1 (en) * 2009-05-29 2010-12-02 Dsm Ip Assets B.V. Transfer matrix for transferring a bioactive agent to body tissue
MX2013008476A (es) 2011-02-17 2013-08-12 Hoffmann La Roche Proceso para cristalizacion controlada de un ingrediente farmaceutico activo a partir del estado liquido superenfriado por extrusion de fusion en caliente.
CA2848493A1 (en) * 2011-09-14 2013-03-21 Celgene Corporation Formulations of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
JPH054919A (ja) * 1990-07-25 1993-01-14 Sankyo Co Ltd チアゾリジン誘導体の固体分散体
KR0182801B1 (ko) * 1991-04-16 1999-05-01 아만 히데아키 고체 분산체의 제조방법
AU671811B2 (en) * 1991-12-18 1996-09-12 Warner-Lambert Company A process for the preparation of a solid dispersion
US5340591A (en) * 1992-01-24 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
DE4226753A1 (de) * 1992-08-13 1994-02-17 Basf Ag Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
JPH07324086A (ja) * 1994-05-31 1995-12-12 Sankyo Co Ltd チアゾリジン誘導体の固体分散体または固体分散体製剤
DE19515972A1 (de) * 1995-05-02 1996-11-07 Bayer Ag Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
NZ502869A (en) 2002-10-25
AU8600098A (en) 1999-03-08
WO1999008660A1 (en) 1999-02-25
ZA987551B (en) 1999-02-23
US20010048946A1 (en) 2001-12-06
EP1011640A1 (en) 2000-06-28
CA2292586A1 (en) 1999-02-25
KR20010023085A (ko) 2001-03-26
SV1998000104A (es) 1999-07-02
BR9811972A (pt) 2000-08-15
PA8458101A1 (es) 2001-12-14
AR018252A1 (es) 2001-11-14
CA2292586C (en) 2006-02-14
PE109599A1 (es) 1999-12-19
HN1998000115A (es) 1999-06-02
JP2001515029A (ja) 2001-09-18
CO4960652A1 (es) 2000-09-25

Similar Documents

Publication Publication Date Title
GT199800136A (es) Formas de dosificacion farmaceuticas solidas.
ID27504A (id) Formulasi oral baru
BR0009437A (pt) Amido pré-gelatinizado em uma formulação de liberação controlada
BR0014320A (pt) Composições de substâncias terapêuticas solúveis em tocol
YU35302A (sh) Dozirani oblik leka sa inicijalnim hidrogelom
AR036972A1 (es) Tableta bioadhesiva de hidratacion progresiva y liberacion sostenida y su uso en la fabricacion de un agente farmaceutico
PT954314E (pt) Formas de dosagem farmaceutica para melhorar a disfuncao erectil masculina
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
PT1183014E (pt) Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
CY1105211T1 (el) Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη
AR032293A1 (es) Estuche farmaceutico
UY25544A1 (es) Forma de dosificación de nefazodona
BG108516A (en) Pharmaceutical formulation
ES2166988T3 (es) Terapia de administracion uniforme de farmacos.
ATE541562T1 (de) Ibuprofen-suspension
BR0112847A (pt) Uso de uma forma de dosagem sólida
DZ3473A1 (fr) Formulation pharmaceutique a liberation prolongee independante de la force ionique.
AR033012A1 (es) Combinaciones antineoplasicas
SE0001916D0 (sv) Novel formulation
DE69918711D1 (de) Amphiphile polyamin verbindungen
IT1318509B1 (it) Polimeri reticolati, utili per uso farmaceutico, medicale e cosmetico.
ES2171080T3 (es) Composicion para la mejora de la fertilidad y su aplicacion.
UY26503A1 (es) " forma de dosificación de fármacos accionada por un hidrogel"
ECSP972253A (es) Composicion farmaceutica: nueva formulacion y su uso en el tratamiento y/o profilaxis de ciertos trastornos